• +357 22 373089
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

Mission Statement

mission1EPOS-IASIS (www.epos-iasis.com) is a vibrant nano-biotechnology SME in Cyprus, established in 2006 as the First Prize Winner of the Cyprus Entrepreneurship Competition (CyEC). The vision of EPOS-IASIS is to become a long standing reliable partner in health care and establish itself as a leading research, development and education enterprise in the European environment. EPOS has amassed expertise in the translational nanotheranostics, molecular imaging and cell-based technologies, harnessing moleculers and light for faster diagnosis and better prognosis. EPOS has established the only setting for BRET/FRET technology in Cyprus and is considered a regional leader in translational nanotheranostics. In the first 10 years of life, EPOS has co-ordinated numerous national and one major FP7-IAPP grant and has participated as a major partner in FP7 projects, bridging the academic with the entrepreneurial spirit across sectors. Emission2POS has filed international patents in theranostics, new CNT-delivery systems for brain tumors and on multifunctional conjugares for metastatic Cancer The strategy of EPOS-IASIS is to partner with other flexible teams through the research and development phases and with well-established pharmaceutical and biomedical engineering firms for the testing, productions and selling of our products.

Recognized as a leading regional nanobiotechnology R&D SME in its field, EPOS collaborates with over 25 organisations worldwide. EPOS’s collaborators range from world-renowned academic institutions, in Europe and the United States, to large industrial partners, government organisations, and small and medium size enterprises that are seeking solutions to translational nanomedicine and molecular oncology problems. For example, the enterprise has strong collaborations with the National Medical and Public Health Services and the Brain Tumour Patient Association, which are supporting its research activities but are also partnering the expertise of EPOS in the establishment of a National Brain Tumour Biobank, paving the way towards advanced molecular therapeutics.


3 Saint Theophanous Street,
Suite 101,
Nicosia 2055, Cyprus

Telephone: +357 22 373089

Email: inf[at]epos-iasis.com


© 2024 EPOS-Iasis Research and Development, Ltd. All Rights Reserved.